CLOSE X
GO

Aditya Birla SL Pharma & Healthcare Fund-Reg(G)

very highequitypharma & health care
30.29 -0.12(-0.39%) NAV as on 13 Jun 2025
2.89 % 1 M
10.31 % 1 Y
23.07 % 3 Y

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • max

FUND OBJECTIVE

Investment objective of the scheme is to provide long term capital appreciation by investing in equity & equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.The Scheme does not guarantee/indicate any returns. There can be no assurance that the schemes objectives will be achieved.

SCHEME DETAILS

expense_ration-icon Expenses Ratio :

2.33

As on 30 Apr, 2025
age-icon Age :

5 yrs 11 m

Since 10 07 ,2019
exit_load Exit Load :

1%

aum AUM :

814.18 Crs

lock_in Lock-in :

1% on or before 30D, Nil after 30D

investing_style Investing Style :

Large Growth

Portfolio_book_value Portfolio Price To Book Value :

8.74

Min_Investment Min. Investment :

SIP 100 & Lumpsum 1000

Scheme_benchmark Scheme Benchmark :

NA

Fund_manager Fund Manager :

Dhaval Shah,Dhaval Joshi

LATEST ASSET & PORTFOLIO ALLOCATION

as on May 31 ,2025
Others 2.06 %
Equity 97.94 %

TOP HOLDINGS

Sun Pharmaceutical Industries...12.08 %
Cipla Ltd.7.69 %
Apollo Hospitals Enterprise Ltd.7.18 %
Abbott India Ltd.6.09 %
Torrent Pharmaceuticals Ltd.5.47 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs76.75
Hospital & Healthcare Services18.71
Business Support1.59
Chemicals0.88
See All Sectors

5-YEARS HISTORY

Financial Year2020-20212021-20222022-20232023-20242024-2025
NAV in Rs (as on 31-Mar-2025)16.1218.2216.3626.4529.39
Net Assets(Rs Crores) (as on 31-Mar-2025) 454.91 515.33 428.44 699.55 814.95
Scheme Returns(%)(Absolute)63.4912.40-10.2661.3810.03
B'mark Returns(%)(Absolute)NANANANANA
Category Rank55/7549/7570/7611/9032/102

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

Aditya Birla SL Pharma & Healthcare Fund-Reg(G)Very HighEquity30.29-0.12(-0.39%)NAV As on 13 Jun, 202510-Jul-2019Inception Date814.18AUM In Cr.10.31%1Y23.07%3Y19.21%5Y20.54%Since Inception
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Very HighEquity39.37-0.05(-0.13%)NAV As on 13 Jun, 202513-Jul-2018Inception Date5,507.52AUM In Cr.21.93%1Y29.75%3Y25.03%5Y21.89%Since Inception
SBI Healthcare Opp Fund-Reg(G)Very HighEquity426.54-0.14(-0.03%)NAV As on 13 Jun, 202514-Jul-1999Inception Date3,689.28AUM In Cr.19.31%1Y29.09%3Y24.17%5Y16.31%Since Inception
Nippon India Pharma Fund(G)Very HighEquity513.89-0.74(-0.14%)NAV As on 13 Jun, 202505-Jun-2004Inception Date8,352.16AUM In Cr.13.72%1Y25.49%3Y21.99%5Y20.60%Since Inception
ATTENTION INVESTORS NSDL/CDSL KYC Advisory for investors